Lithium citrate

• UNSPSC Description:

  Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease[1].

• Target Antigen:

  Others

• Type:

  Reference compound

• Related Pathways:

  Others

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/lithium-citrate.html

• Solubility:

  10 mM in DMSO

• Smiles:

  O=C(CC(C(O[Li])=O)(CC(O[Li])=O)O)O[Li]

• Molecular Weight:

  209.92

• References & Citations:

  [1]Mitra Assadi, et al. Lithium citrate reduces excessive intra-cerebral N-acetyl aspartate in Canavan disease. Eur J Paediatr Neurol. 2010 Jul;14(4):354-9.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Launched

• CAS Number:

  919-16-4